Google Ventures
VC Fund
Mountain View, United States
Google Ventures is a VC fund in Mountain View focused on Software and Health Care. Google Ventures invests in sectors including life sciences, consumer, enterprise, crypto, climate, and frontier technology. With Alphabet as its sole limited partner, Google Ventures focuses on long-term investments. Its operating partners assist startups in design, equity, diversity & inclusion, talent, and engineering and help them connectwith Google for technology and expertise. Founded in 2009 as Google Ventures, Google Ventures manages over $8 billion in assets with 400 active portfolio companies in North America and Europe. Some notable investments include Uber, Nest, Slack, GitLab, and One Medical. Google Ventures is based in the San Francisco Bay Area with offices in Cambridge, New York, and London.
- Total investments:
- 1248
- Last investment:
- Lead investor:
- 30%
- Fund size:
- $100M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Google Ventures invests in
Stages Google Ventures invests in
Countries Google Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.1M–$17M
- Series A
- $6M–$101M
- Series B
- $16M–$125M
Investment Focus
Industry
- Software 171 (14%)
- Health Care 111 (9%)
- Biotechnology 102 (8%)
- SaaS 65 (5%)
- Artificial Intelligence 65 (5%)
Stage
- Series A 219 (18%)
- Series B 206 (17%)
- Seed 153 (12%)
- Series C 128 (10%)
- Series D 76 (6%)
Country
- United States 525 (42%)
- United Kingdom 35 (3%)
- Israel 4 (0%)
- Switzerland 4 (0%)
- Canada 2 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Andy Wheeler
Partner
|
Partner | Total investments: 34 | Find email | |
|
Anika Gupta
Principal
|
Principal | Total investments: 4 | Find email | |
|
Anthony Philippakis
Venture Partner
|
Venture Partner | Total investments: 23 | Find email | |
|
Ben Robbins
General Partner
|
General Partner | Total investments: 24 | Find email | |
|
Bethany Tsui
Principal and Investor
|
Principal and Investor | Total investments: 0 | Find email | |
| See all 24 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Discovering powerful new drugs from eukaryotic microbes by combining Genomics with AI and Synthetic Biology. Founded by Gregory Verdine, PhD, Rick Klausner, MD and WeiQing Zhou, MBA, LifeMine Therapeutics is headquartered in Cambridge, Massachusetts. | $188M / Series E / Aug 06, 2026 | |
|
|
Led by former founding team members of Cylance and Carbon Black, Obsidian Security is a Southern California technology company living at the intersection of cybersecurity, artificial intelligence, and hybrid-cloud environments. Backed by Greylock Partners, Obsidian Security is based in Newport Beach, CA. | $85M / Series D / Aug 04, 2026 | |
|
|
Wonder is a food technology company that operates a mealtime platform offering restaurant meals, prepared foods, meal kits, and food delivery through a unified ordering experience. It develops and manages food preparation, ordering, and delivery using proprietary technology, including its Infinite Kitchen food robotics platform. The companypartners with chefs and restaurant brands to provide a variety of meal options that customers can order through its platform. It also manages the preparation and fulfillment process to support delivery and pickup services across its locations. Additionally, Wonder expands its food ecosystem through the operation and integration of restaurant concepts, meal kit services, and delivery capabilities. | $650M / Series D / Jul 16, 2026 | |
|
|
NEBEX is a successful middle market investment intermediary. NEBEX, has completed over 100 transactions throughout the United States. New England Business Exchange concentrates on representing sellers whose business appeals to large corporate buyers or private equity groups. | $30M / Seed / Jun 29, 2026 | |
|
|
Verse helps large energy buyers Connect, Contain, and Control their global power portfolios: connect to the grid faster leveraging flexibility; contain energy cost and risk with real-time analytics and strategic procurement; and control assets to maximize portfolio value through real-time optimization. Verse team blends deep energy-market expertisewith modern software engineering and product design to deliver usable, scalable tools to manage power costs and risks. | $54M / Series B / Jun 18, 2026 | |
|
|
Odyssey operates as an AI start-up, provides hollywood-grade visual AI. | $310M / Series B / Jun 17, 2026 | |
|
|
Flourish Labs is a research and development company that combines certified humans, technology, and AI to provide every employee with a dedicated coach. The company builds AI-powered platforms for peer mental health support, focused on making mental health care accessible. | $500M / Series A / Jun 04, 2026 | |
|
|
Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam isnon-hormonal, designed to last years, and easily reversible. | $92.5M / Series B / Jun 02, 2026 | |
|
|
Mokn operates as a smartest way to end credential threats. | $15M / Series A / May 29, 2026 | |
|
|
Signos is on a mission to tackle the obesity epidemic via healthy habits, glucose level stabilization, and AI. Signos combines continuous glucose information with an AI-enhanced app to offer revolutionary continuous data and recommendations designed to drive healthy and sustained weight loss. With over 75% of the American population overweight orobese, Signos provides a new way for people to act on their body’s unique response to what they eat to lose weight and kickstart a healthier life | $20M / Venture - Series Unknown / May 27, 2026 | |
| See all 1248 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Google Ventures invest in?
Google Ventures invests primarily in Software, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 1,248 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Google Ventures's check size?
Google Ventures typically joins rounds of $1.1M–$17M at Seed, $6M–$101M at Series A and $16M–$125M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Google Ventures participates in.
How do I contact Google Ventures?
Public channels for Google Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Google Ventures?
The team at Google Ventures includes Andy Wheeler (Partner), Anika Gupta (Principal) and Anthony Philippakis (Venture Partner), among 24 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!